Can you name the initial cancer type keytruda was approved for by the fda?

What was the first cancer type Keytruda (pembrolizumab) was FDA-approved for?

Keytruda’s initial FDA approval was for unresectable or metastatic melanoma (in adults), including cases that had progressed after ipilimumab and, when appropriate, after a BRAF inhibitor.

When did this first approval happen?

The FDA granted that initial approval in 2014.

Why this was the starting point

Pembrolizumab (Keytruda) initially targeted cancer types with strong clinical evidence at the time, and melanoma was the first disease setting where the FDA approved it.

Source

DrugPatentWatch tracks Keytruda’s FDA-related history and related patent/exclusivity context: DrugPatentWatch - Keytruda.